Leo Lens Technology Inc, now known as MediPrint Ophthalmics, is a San Diego-based clinical stage eye care pharmaceutical company that specializes in developing and commercializing a unique ocular drug delivery portfolio. Their innovative solution involves the use of drug-eluting contact lenses to provide continuous medication delivery, offering a safe, effective, and convenient treatment option for millions of patients worldwide suffering from ocular diseases.
Recognizing the limitations of traditional eye drops, which often result in patient non-compliance, low bioavailability, and adverse effects, MediPrint Ophthalmics aims to revolutionize eye care by utilizing their proprietary MediPrint process. By layering FDA-approved drugs onto contact lenses, their therapy provides sustained and non-invasive dosing, enhancing comfort and minimizing side effects. With promising results from their clinical studies, MediPrint Ophthalmics is poised to become a future standard of care in the field of eye care pharmaceuticals.
Generated from the website